Matches in Nanopublications for { ?s ?p "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP570111.RAQ1AGEodT8n7by-4cny2ZN5NYX_EIm1mTxW6jfCm3fiA130_provenance.
- NP295618.RAzV3zpxY7nxweZS39nQM5HTz3JyOpC2y5HgU0gBZNkHI130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295618.RAzV3zpxY7nxweZS39nQM5HTz3JyOpC2y5HgU0gBZNkHI130_provenance.
- assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP651600.RA_XdBA___q4wF40uUFCrvpXkA2axL-KgwdK9bPhTDGsY130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651600.RA_XdBA___q4wF40uUFCrvpXkA2axL-KgwdK9bPhTDGsY130_provenance.
- NP507979.RANVpFGBXNM9K3xxtZIx02XLJEcJ_7_C7WX_bJFEr4Xyk130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507979.RANVpFGBXNM9K3xxtZIx02XLJEcJ_7_C7WX_bJFEr4Xyk130_provenance.
- assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP390331.RAabE14hfXZKDiIKHT0dpnwHBQTWCEeV1paiuvrXvD8CY130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390331.RAabE14hfXZKDiIKHT0dpnwHBQTWCEeV1paiuvrXvD8CY130_provenance.
- NP916021.RAANUPVlEb8ZHkiMk2OTNZeSqOPWIXHxQh9BzoZ0nVubY130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916021.RAANUPVlEb8ZHkiMk2OTNZeSqOPWIXHxQh9BzoZ0nVubY130_provenance.
- NP781864.RAK3Tkrn9VHxuYtVs32tUk5NVrUINQNcl0FLNpQSYJUrA130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781864.RAK3Tkrn9VHxuYtVs32tUk5NVrUINQNcl0FLNpQSYJUrA130_provenance.
- NP390329.RArHFkw-LAYIIqDBzu_lT0pyLNFyV2d9MGEJ6XpqS46AE130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390329.RArHFkw-LAYIIqDBzu_lT0pyLNFyV2d9MGEJ6XpqS46AE130_provenance.
- NP390332.RAiU6pv3cy0rj033pD-vzjQe1sMyg8gAscj1ybeZlxQVA130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390332.RAiU6pv3cy0rj033pD-vzjQe1sMyg8gAscj1ybeZlxQVA130_provenance.
- NP920284.RAPg2nY95lSeYqj2EoGwWpPntlS2MWf_wL6P8NzKIksCE130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920284.RAPg2nY95lSeYqj2EoGwWpPntlS2MWf_wL6P8NzKIksCE130_provenance.
- NP390334.RA7b7HuxWn-6YNKdEkKxXWLs378fe9CLST-lyWtkCjl4E130_assertion description "[FGFR2 is an oncogene amplified in diffuse-type gastric cancer, and WDR11 is a tumor suppressor gene disrupted in glial tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390334.RA7b7HuxWn-6YNKdEkKxXWLs378fe9CLST-lyWtkCjl4E130_provenance.